In other studies, using DIO mice, treatment with ObR: Fc or with anti-PD-1 increased cytokine secretion and costimulatory molecule expression on CD8+ T cells, improved tumor size control, and restored immunotherapy efficacy [173,174]. This evidence concerns the gene CD8A and neoplasm.